In this study, we found that miR-589-5p was down-regulated in CD90+ CSCs and examined the effects of miR-589-5p expression and its target protein MAP3K8 on CD90+ CSCs and the clinical outcomes of HCC. The gene discussed is MAP3K8; the disease is hepatocellular carcinoma.